Peter S. DiStefano
Affiliations: | Elixir Pharmaceuticals, Cambridge, MA, United States |
Area:
Neurotrophins,Google:
"Peter DiStefano"Mean distance: 15.17 (cluster 11) | S | N | B | C | P |
Cross-listing: Chemistry Tree
Parents
Sign in to add mentor| Oliver M. Brown | grad student | Syracuse | |
| Eugene M. Johnson | post-doc | Washington University School of Medicine |
Children
Sign in to add trainee| James R. Tonra | post-doc | Regeneron Pharmaceuticals | |
| Rory Curtis | post-doc | 1991-1995 | Regeneron Pharmaceuticals |
| John J. Byrnes | research scientist | Elixir Pharmaceuticals | |
| Brad J. Geddes | research scientist | Millennium Pharmaceuticals | |
| Michael Jacobson | research scientist | Millennium Pharmaceuticals | |
| Michael Yu Xie | research scientist | 1998-2001 | Millennium Pharmaceuticals |
| Mats H. Holmqvist | research scientist | 2000-2004 | Millennium Pharmaceuticals |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Agoulnik IU, Kaftanovskaya EM, Myhr C, et al. (2024) Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology. Biochemical Pharmacology. 116401 |
| Tacke C, DiStefano PS, Lindsay RM, et al. (2022) Actions of the TrkB Agonist Antibody ZEB85 in Regulating the Architecture and Synaptic Plasticity in Hippocampal Neurons. Frontiers in Molecular Neuroscience. 15: 945348 |
| Ateaque S, Merkouris S, Wyatt S, et al. (2022) Selective activation and down-regulation of Trk receptors by neurotrophins in human neurons co-expressing TrkB and TrkC. Journal of Neurochemistry |
| Merkouris S, Barde YA, Binley KE, et al. (2018) Fully human agonist antibodies to TrkB using autocrine cell-based selection from a combinatorial antibody library. Proceedings of the National Academy of Sciences of the United States of America |
| Longo KA, Govek EK, Nolan A, et al. (2012) Pharmacologic inhibition of ghrelin receptor signaling is insulin sparing and promotes insulin sensitivity (Journal of Pharmacology and Experimental Therapeutics (2011) 339, (115-124)) Journal of Pharmacology and Experimental Therapeutics. 340: 810 |
| Longo KA, Govek EK, Nolan A, et al. (2011) Pharmacologic inhibition of ghrelin receptor signaling is insulin sparing and promotes insulin sensitivity. The Journal of Pharmacology and Experimental Therapeutics. 339: 115-24 |
| Qi Y, Longo KA, Giuliana DJ, et al. (2011) Characterization of the insulin sensitivity of ghrelin receptor KO mice using glycemic clamps. Bmc Physiology. 11: 1 |
| Longo KA, Charoenthongtrakul S, Giuliana DJ, et al. (2010) The 24-hour respiratory quotient predicts energy intake and changes in body mass. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 298: R747-54 |
| Longo KA, Berryman DE, Kelder B, et al. (2010) Daily energy balance in growth hormone receptor/binding protein (GHR -/-) gene-disrupted mice is achieved through an increase in dark-phase energy efficiency. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 20: 73-9 |
| Charoenthongtrakul S, Giuliana D, Longo KA, et al. (2009) Enhanced gastrointestinal motility with orally active ghrelin receptor agonists. The Journal of Pharmacology and Experimental Therapeutics. 329: 1178-86 |